Keros Therapeutics Inc (KROS)
$60.90 $0.22 (0.37%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.14B -
Day's Range
$59.50 - $61.01 -
Volume
406,456 -
52 Week Low / High
$27.02 - $73.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
KROS's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 8
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $88.86
- Target Price
Company News
-
Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference — Sep 12th, 2024
Keros Therapeutics, Inc. LEXINGTON, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patien...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$